Home/Companies/Biotech/GenSight Biologics

GenSight Biologics

Biotech·

France·Active

Entry

–

Hold

–

Status

Active

Who owns GenSight Biologics?

GenSight Biologics is a French Biotech company, currently owned by Sofinnova Partners.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY

Most recent investor

Sofinnova Partners

Sofinnova Crossover Fund I · 2018 · VC

3 ownership periods · full history below

Key facts

HQFrance

SectorBiotech

Websitewww.gensight-biologics.com

Key takeaways

·Held by Sofinnova Partners since n/a.
·Average hold across 2 realized cycles: 3 years.

Ownership history

3 ownership periods · co-invest detected

Active

Currently held by Sofinnova Partners.

Co-invest · 2 holders · 2012 · 2016

IbionextExited 2016

2012 · 2016(4yr) · iBionext Growth Fund · 2018 · VC

IPO

Ibionext took GenSight Biologics public via IPO in 2016 after 4 years.

AbingworthExited 2016

2014 · 2016(2yr) · Abingworth Bioventures VI · 2014 · Life Sciences VC

IPO

Abingworth took GenSight Biologics public via IPO in 2016 after 2 years.

Sofinnova PartnersActive

present · Sofinnova Crossover Fund I · 2018 · VC

More from Sofinnova Crossover Fund I

Other portfolio companies in the same fund.

Sphere Bio (formerly Sphere Fluidics)

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare

Active

The Carlyle GroupChina

Adagene

Active

General AtlanticChina

Advanced Cell Diagnostics

Questions

Who owns GenSight Biologics?

GenSight Biologics is currently owned by Sofinnova Partners, through Sofinnova Crossover Fund I.

Who has owned GenSight Biologics over time?

GenSight Biologics has been through 3 private-equity ownership periods: Ibionext · via iBionext Growth Fund · 2012–2016 · (IPO); Abingworth · via Abingworth Bioventures VI · 2014–2016 · (IPO); Sofinnova Partners · via Sofinnova Crossover Fund I.

Look up another firm or company

Data refreshed weekly · Sourced from public filings · Report an issue